Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
When chemists design drug candidates, shape matters enormously. Many active pharmaceutical ingredients contain branched ...
A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results